235 East 42nd Street
United States - Map
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments. The GIP segment develops, registers, and commercializes medicines for various therapeutic areas, including inflammation, cardiovascular/metabolic, neuroscience and pain, rare diseases, and womens/mens health. The VOC segment develops and commercializes vaccines, as well as products for oncology. It also provides over-the-counter products comprising dietary supplements under the Centrum, Caltrate, and Emergen-C brands; pain management products under the Advil and ThermaCare brands; gastrointestinal products under the Nexium 24HR/Nexium Control brand; respiratory products under the brand names of Robitussin, Advil Cold & Sinus, Advil Congestion Relief, and Dimetapp; and personal care products under the ChapStick and Preparation H brands. The GEP segment offers patent-protected products that have lost marketing exclusivity in various markets; and generic pharmaceuticals, and sterile injectable and biosimilar development products. The company serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as centers for disease control and prevention. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
|Pfizer Inc.’s ISS Governance QuickScore as of Feb 1, 2015 is 3. The pillar scores are Audit: 1; Board: 5; Shareholder Rights: 7; Compensation: 1.|
|Brought to you by Institutional Shareholder Services (ISS)|
|Mr. Ian C. Read ,
Chairman, Chief Exec. Officer and Chairman of Exec. Committee
|Mr. Frank A. D'Amelio ,
Chief Financial Officer and Exec. VP of Bus. Operations
|Prof. Mikael Dolsten Ph.D.,
Pres of Worldwide R&D
|Mr. Geno J. Germano ,
Group Pres of Global Innovative Pharma Bus.
|Mr. John D. Young ,
Group Pres of Global Established Pharma Bus.
|Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|